Defective recruitment of regulatory T cells (Treg) function to the airway is important in the pathogenesis of allergic asthma. Complement regulatory protein (CD46) is a newly defined costimulatory molecule for Treg activation, which together with IL-10/granzyme B production may aid in suppressing asthmatic inflammation. This study examines chemotaxis and adhesion molecule expression on CD3/CD46-activated CD4 þ T cells (Tregs) from patients with and without asthma to suppress mite allergen-induced respiratory epithelial cells inflammation and to elucidate the mechanism of CD46-mediated Treg activation. Diminished IL-10/granzyme B and CCR4 expression from CD3/CD46-activated Tregs appeared in asthmatic subjects. CD3/CD46-activated Tregs from asthma patients co-cultured with BEAS-2B cells suppressed Dermatophagoides pteronyssinus 2 induced nuclear factor-kB/p65 by cell contact inhibition. Decreased interaction of CD3/CD46-mediated Tregs and BEAS-2B cells from asthmatics was associated with downregulated phosphorylation of protein kinase B (AKT) expression. Results provide the first evidence that decreased interaction between CD46-mediated Tregs and lung epithelial cells with less IL-10/granzyme B production may cause airway inflammation in allergic asthma.
, Ya-Ju Yeh 1 , Chia-Ying Lee 6 and Ching-Yuang Lin 6, 7 Defective recruitment of regulatory T cells (Treg) function to the airway is important in the pathogenesis of allergic asthma. Complement regulatory protein (CD46) is a newly defined costimulatory molecule for Treg activation, which together with IL-10/granzyme B production may aid in suppressing asthmatic inflammation. This study examines chemotaxis and adhesion molecule expression on CD3/CD46-activated CD4 þ T cells (Tregs) from patients with and without asthma to suppress mite allergen-induced respiratory epithelial cells inflammation and to elucidate the mechanism of CD46-mediated Treg activation. Diminished IL-10/granzyme B and CCR4 expression from CD3/CD46-activated Tregs appeared in asthmatic subjects. CD3/CD46-activated Tregs from asthma patients co-cultured with BEAS-2B cells suppressed Dermatophagoides pteronyssinus 2 induced nuclear factor-kB/p65 by cell contact inhibition. Decreased interaction of CD3/CD46-mediated Tregs and BEAS-2B cells from asthmatics was associated with downregulated phosphorylation of protein kinase B (AKT) expression. Results provide the first evidence that decreased interaction between CD46-mediated Tregs and lung epithelial cells with less IL-10/granzyme B production may cause airway inflammation in allergic asthma. Loss of regulatory T (Treg) cells function appears critical to human allergic asthma pathogenesis. 1 Tolerance to environmental allergens encountered on respiratory mucosal surfaces could be mediated by the development of Treg cells to suppress airway inflammation. [1] [2] [3] Attention has focused on defects of natural occurring CD4 þ CD25 þ Treg cells that regulate inflammatory response in asthmatic. 4, 5 Adaptive regulatory T (Tr1) cells secreting immunosuppressive cytokines may have a key role in maintaining immune tolerance to allergen in asthma. 6, 7 For recruiting allergen-specific T cells to the lungs, the expression of specific adhesion proteins and chemokine receptors is vital. 8 Evidence from pediatric asthmatic subjects show that CD4 þ CD25 hi þ Treg cells decrease in bronchoalveolar lavage fluid and fail to inhibit pulmonary TH2 responses, suggesting functional defective recruitment to the site of airway inflammation. 9 Still, little is known about migration and retention mechanisms of Tregs and inducible Tr1 to airway where they maintain suppressive effectiveness in asthma. 10 Studies reveal the complement system is activated locally and systemically to amplify inflammatory response in allergic asthmatics. 11 Complement regulatory protein CD46, widely expressed in human leukocytes, epithelial cells and fibroblasts, is upregulated on certain activated leukocytes subsets to protect cells from autologous complement-mediated lysis at inflammatory sites. [12] [13] [14] [15] [16] The mechanism for CD46 modulation of regulating T cells is addressed as (i) induction of T-cell proliferation, (ii) induction of Tr1 differentiation; and (iii) competition effect of IL-2 on the Th1/Tr1 balance. Cross-linking of CD46 during TCR activation leads to strong CD4 þ T-cell proliferation and synthesis of large amounts of IL-10 and granzyme B, similar to inducible Tr1 cells. [17] [18] [19] [20] [21] CD46 -costimulated human T cells differentiate toward a Th1  response with secreting IFN-g, IL-10, granzyme B and compete for IL-2 as a growth factor may have a role in immune  tolerance against allergic inflammation.  22-24 Defective CD46-costimulation Treg regulating immune responses correlates  with autoimmune disease in multiple sclerosis. 25 -27 Xu et al first demonstrated CD46-costimulated T cells acquiring a Tr1 phenotype with IL-10 production as impaired in a small group of asthma patients. 28 We hypothesize mite-induced bronchial epithelial inflammation as deficiency in chemokine receptor expression by CD3/CD46-induced CD4 þ T cells (Tregs), leading to failed recruitment and reduced suppression at sites of allergic inflammation.
This study performed quantitative and functional analysis of CD3/CD46-activated Tregs in asthma patients to suppress recombinant D. pteronyssinus 2 (Der p 2)-induced bronchial epithelial BEAS-2B cells inflammation with nuclear factor (NF)-kB. We examined migratory potential of CD3/CD46-activated Tregs, including expression of chemokine receptors. This study evaluated adhesion ability between CD3/CD46-induced Treg and Der p 2 preactivated BEAS-2B cells, specifically with intracellular adhesion molecule-1 (ICAM-1) and chemokine intracellular signaling pathway, including protein kinase B (AKT) phosphorylation. Such research can elucidate CD3/CD46-activated Treg recruitment mechanisms, both in suppressing airway inflammation and in novel immunotherapeutic asthma treatment.
MATERIALS AND METHODS Subjects
A total of 60 mild intermittent to moderately persistent asthmatic children (28 boys and 32 girls; mean age 13.7 ± 3.8 years) with sensitivity to house dust mites (Der p), demonstrated by positive skin prick test (mean grade 3.3 ± 0.7) and IgE-specific test (mean 73.2 ± 24.5 KU/L) using the CAP system (Pharmacia Diagnostics, Uppsala, Sweden), were enrolled in this study. Definition of asthma was based on GINA guideline. Another 31 boys and 29 girls (mean age 13.2±4.5 years) with normal serum IgE levels and negative for skin prick tests were recruited as healthy controls. The hospital's institutional review board approved the study, and parents of all subjects provided written informed consent.
Antibody and Reagents
Recombinant Der p 2 (Indoor Biotechnologies, Cardiff, UK) served as allergen. Nuclear factor-kB (NF-kB)/p65, antiphopspho-AKT, b-actin was obtained for western blot analysis (Abcam, Cambridge, UK) Anti-human CD4, CD46, CD8, CCR4, CCR5, CCR7, CCR8, ICAM-1, pan Cytokeratin, granzyme B, IFN-g, IL-10 mAbs and isotype-matched mAbs conjugated with FITC, PE and PC5 and neutralizing anti-IL-10 mAb, were obtained from BD Biosciences (San Jose, CA) and Abcam.
Tissue Sample, Cell Isolation and Cell Culture Bronchial mucosal specimens were taken by bronchoscopic biopsies according to the British Thoracic Society guidelines and lymphocytes were isolated directly after surgery for confocal immunofluorescence. Peripheral mononuclear cells (PBMCs) were isolated by Ficoll-paque gradient centrifugation (Pharmacia, Uppsala, Sweden). CD4 þ T cells were purified from PBMCs, using microbeads according to manufacturer's protocol (BD Biosciences). Purity of CD4 þ T-cell population analyzed by flow cytometry was Z95%. A total of 1 Â 10 6 CD4 þ T cells were cultured with IL-2 (10 m/ml), anti-human CD3 mAb (2 mg/ml) with anti-human CD28 mAb (5 mg/ml) or anti-human CD46 mAb (5 mg/ml) (BD Biosciences) for 5 days. Confluent monolayer BEAS-2B cells (human bronchial epithelial cell line, American Type culture Collection, Rockville, MD) were cultured with or without CD3/CD46-activated CD4 þ T cells in RPMI-1640 medium containing 10% fetal bovine serum (Bio-Whittaker, Walkersille, MD).
Flow Cytometry and Cell Proliferation Assay
PBMCs were fixed and stained for fluorescein-conjugated mAbs with isotype, CD46, CD4 and CD8. Chemokine receptors with CCR4, CCR5, CCR7 and CCR8, as well as intracellular IL-10 and IFN-g cytokines staining of CD3/CD46-activated CD4 þ T cells were determined by flow cytometry (FC500, Beckman Coulter, Fullerton, CA). To evaluate CD3/CD46-activated CD4 þ T proliferation, CD4 þ T cells were labeled with 5 mM CFSE (Invitrogen, Carlsbad, CA) for 15 min at 37 1C. Cells were washed twice and stimulated with IL-2, anti-CD3 mAb and anti-CD46 mAb for 5 days, as previously described. At the end of culture, CD4 þ T cells proliferation was rated by CFSE fluorescence with flow cytometry.
Confocal Immunofluorescence CD3/CD46-stimulated CD4
þ T cells from asthmatic and nonatopic subjects were incubated with a anti-CD46 antibody (Genetex, Irvine, CA), anti-CD4 antibody, antigranzyme B antibody (Abcam), followed by AlexaFluor 488-conjugated anti-rabbit (Invitrogen), or AlexaFluor 546-conjugated antimouse (Invitrogen) secondary antibody, according to manufacturer's instructions. Confocal immunofluorescence pictures were taken by Leica TCS SP2 confocal spectral microscope.
Enzyme-Linked Immunosorbent Assay (ELISA) IFN-g and IL-10 concentrations of cell supernatants were determined by commercially available ELISA-based assay systems (R&D Systems, London, UK). Assay was performed as per manufacturer's protocol.
Real-Time Quantitative Reverse TranscriptionPCR (RT-PCR) Analysis
Cyt1 and Cyt2 transcription factors mRNA were analyzed by SYBR Green PCR Kit (Applied Biosystems, California). Specific primers were used: Cyt1: sense 5 0 -CTAACTGATGA
0 -GAAGCATTTGCGGTGGACGAT-3 0 , as previously published. 25 Cyt1 and Cyt2 mRNA expression was calculated as fold change using formula 2
DCt DC T ¼ DC T (control)ÀDC T (target), in which C T indicates cycle threshold.
Transepithelial Migration and Cell Adhesion Assay
To determine whether CD3/CD46-activated CD4
þ Treg cells migrate across BEAS-2B cells via Der p 2 stimulation, time course of in vitro transepithelial migration model was used. 29 Lower and upper chambers were separated by a culture insert with polycarbonate membrane (5-mm pore size), using a 24-well Micro Chemotaxis Transwell (Corning Costar, Cambridge, MA). Confluent BEAS-2B cells were cultured and seeded onto the bottom side of culture insert, then preincubated with Der p 2 (10 mg/ml) for 2 h. CD3/CD46-activated CD4
þ T lymphocytes at 1 Â 10 6 cells/ml loaded onto the upper chamber were left to transmigrate at 37 1C in humidified atmosphere with 5% CO2. After incubation for 2, 6, 12 and 18 h, number of migrated CD3/CD46-activated CD4 þ T lymphocytes in the lower compartment was calculated by counting cells under a light microscope. Migration percentage was derived from 30 paired separate experiments.
To analyze further physical interaction of CD3/CD46-induced CD4
þ Tregs with BEAS-2B cells, in vitro imaging assay was set up by CFSE labeled with 1 Â 10 5 CD3/CD46-activated CD4
þ T cells cultured with 1 Â 10 5 BEAS-2B cells in the presence of Der p 2 (10 mg/ml). Serial images were taken at intervals of 10 min for 2 h after culture by time-lapse photography.
Electrophoretic Mobility Shift Assay (EMSA) of NF-jB Activity To examine suppression activity by CD3/CD46-stimulated Treg cells, BEAS-2B cells were pretreated with recombinant Der p 2 (10 mg/ml) for 12 h and confluent BEAS-2B cells (5 Â 10 5 per well) cultured with CD3/CD46-activated CD4 þ T cells (1 Â 10 5 per well) in a six-well plate for 2 h more. CD3/CD46-stimulated Tregs were separated from adherent BEAS-2B by washing with PBS without Treg and epithelial cell purity was examined by light microscope before analyzing for ICAM expression. We also performed double staining with BEAS-2B epithelium marker (pan Cytokeratin) and ICAM-1 to acquire the results. Nuclear proteins from BEAS-2B cells were extracted with Nuclear Extraction Kit (Panomics, Fremont, CA). A biotin end-labeled NF-kB probe (5 0 -AGTTGAGGGACTTTCCCAGGC-3 0 ) was used and NF-kB protein-DNA binding complex was determined using EMSA kit (Panomics), according to manufacturers' instruction.
Western Blot Analysis
Protein levels of NF-kB, phospho-AKT were determined by western blot analysis. Equal amounts of proteins in each study groups were ascertained by Bio-Rad protein assay kit (Bio-Rad, Hercules, CA). Cellular proteins were resolved by 10% SDS-polyacrylamide gel. After electrophoresis, protein levels of nuclear NF-kB/p65, phosphor-AKT by western blot as previously described. 5 
Statistical Analysis
All data were presented as mean ± s.d. Comparisons between asthmatic and healthy control groups were analyzed by Mann-Whitney U-test. Data sets in each study group were compared by Kruskal-Wallis test, followed by the Duncan test, Po0.05 considered statistically significant.
RESULTS

Surface CD46 Expression on CD4
þ Cells Less in MiteSensitive Asthmatics Confocal microscopic analysis of human bronchial mucosa biopsies revealed CD4 þ CD46 þ T cells decreasing in mite-sensitive asthmatics (n ¼ 3) vs nonatopic subjects (n ¼ 3) with essentially identical results (Figure 1a) . To test differential CD46 molecule expression on T lymphocyte subsets by mite allergen stimulation between asthmatic patients and healthy subjects, PBMCs were stimulated with Der p 2, then analyzed by flow cytometry for CD46 surface expression of CD4 þ and CD8 þ T cells simultaneously. Number of CD4 þ CD46 þ cells decreased in asthmatics compared with healthy subjects (Po0.05) ( Table 1) .
Lower Intracellular IL-10 Level of CD3/CD46-Activated Tregs in Asthmatics To study CD3/CD46 cross-linkage on human CD4 þ T lymphocyte proliferation, purified CD4 þ T cells was labeled by CFSE and were stimulated with anti-CD3/CD46 or anti-CD3/CD28 in the presence of IL-2. Proliferation of CD3/ CD46-activated T cells did not significantly differ between healthy donors and asthmatics (Figure 1b) . Experiments were performed to examine IL-10 expression of CD3/CD46-activated CD4 þ T cells (Figure 1d ). The CD3/CD46-activated CD4 þ T cells had significantly higher IL-10 expression (13.2 ± 4.5%) compared with CD3-activated CD4 þ T cells (4.4±3.2%) in healthy controls (Po0.05) (Figure 1e ). IL-10 expression decreased (13.2±4.5% vs 3.8±3.6%, Po0.05) on CD4 þ T cells after CD46 costimulation in asthmatics compared with normal subjects (Figure 1e ). Upon CD28 costimulation of CD4 þ T cells, IL-10 expression decreased in asthmatic compared with normal subjects, albeit not significantly different (12.7 ± 4.9% vs 15.9 ± 5.6%, P40.05) (Figure 1e ). CD3/CD46-activated CD4 þ T cells showed significantly higher IFN-g expression in healthy controls than in asthmatics (Figure 1c) . Experiments were performed CD46-induced regulatory T cells in asthma Y-G Tsai et al on 10 paired samples with essentially identical results. When cytokine secretion was quantified by ELISA, a striking defect with CD46-mediated IL-10 and IFN-g production was observed in asthmatics when compared with controls (Table 2) . 
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between asthmatic and nonatopic subjects. Decreased CD46 expression associated with diminished granzyme B in CD46-activated CD4 þ T cells in asthmatic patients (Po0.05) (Figure 1f ). Experiments were performed on 30 paired samples, with essentially identical results.
Decreased Cyt1 mRNA and Increased Cyt2 mRNA in CD3/CD46-Activated Treg Cells from Asthmatic Patients To explore mechanism whereby CD3/CD46-activated CD4 þ T cells loses IL-10 secretion in asthmatics, both cytoplasmic isoforms of CD46 were examined; Cyt1 inhibits inflammatory reaction, whereas Cyt2 augments inflammation correlating with decreased IL-10 production as proven by mouse model. 12 Quantitative RT-PCR analysis of Cyt1 mRNA and Cyt2 mRNA in CD3/CD46-induced Tregs from asthmatics revealed decreased CD46-Cyt1 isoform mRNA (Figure 2a ) and increased CD46-Cyt2 isoform mRNA (Figure 2b PBMCs after Der p 2 (10 mg/ml) for 5 days was observed in asthmatic patients (n ¼ 60) vs controls (n ¼ 60). *Po0.05 intergroup comparison. Images were taken at intervals of 10 min for 2 h after culture.
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dose-dependent manner (Figure 4a ). Transwell inset experiments (pore size 0.4 mM) also showed that CD3/CD46-activated CD4 þ T cells inhibit Der p 2-induced NF-kB/p65 on BEAS-2B cells, chiefly by cell contact inhibition (Figure 4b) . Figure 4c shows experimental data on 30 paired samples. Decreased CD3/CD46-activated Tregs inhibition of NF-kB activity in Der p 2-activated BEAS-2B cells was confirmed by EMSA (Figure 4d and e) . To test CD3/CD46-activated Tregs suppression of Der p 2-induced inflammation via IL-10 secretion and neutralizing antibody against IL-10 was added to co-cultures. Enhanced NF-kB from BEAS-2B cells in co-cultures with CD3/CD46-induced CD4 þ T cells following treatment with neutralizing anti-IL10 mAb was noted (Po0.05). Three independent experiments yielded virtually identical results (Figure 4e ). Engaging chemokine receptors are proven to control TH2 cell chemotaxis toward alveoli or bronchial lumen to induce allergic inflammation. 8, 30 Chemokine receptor signaling that determines migration and homing of Treg cells into the lung is crucial for an effective interruption of airway inflammation in asthma. [1] [2] [3] [4] 31, 32 Chemokine receptors CCR4, CCR5, CCR7 and CCR8 are observed in Treg trafficking and function at sites of inflammation. 33, 34 Ahern D et al 35 demonstrated downregulation of CCR4 expression upon allergen stimulation of CD4 þ CD25 þ Tregs, precipitating failure to retain at sites of inflammation to attenuate T-cell activation. Data here reveals CD46 stimulation of Treg cells decreasing CCR4 expression in allergic asthma as critical in recruiting Tregs to epithelial surfaces to limit inflammation.
To probe the molecular mechanism for chemotactic responses in suppression of CD46-activated Tregs, cytoplasmic 
isoforms of CD46 (Cyt1 and Cyt2) mRNA expression from CD46-stimulated Tregs in asthma patients were examined. Researchers find that CD3/CD46-activated CD4 þ T cells expressing Cyt1 cytoplasmic domain produce IL-10 and initiate the chemotactic signaling pathway. 12, [36] [37] [38] [39] This study confirmed a defect in IL-10-producing Tregs in asthmatics, 28 by showing decreased Cyt1 expression; differential integrin/chemokine receptor expression, and lower AKT phosphorylation.
Although Tregs are reported in inflamed peripheral tissue, little is known about signals for recruiting Tregs to epithelial surfaces. 40 Bronchial epithelial cells yielding chemokines and proinflammatory signals in response to inhaled allergens relate to development of human asthma. 44 Transcription factor, NFkB, has a key regulatory role in airway inflammation. Modulated NF-kB activation may provide therapeutic strategy to inhibit inflammatory mediators in asthma. 45, 46 To address functional significance of epithelium-derived NF-kB activation that cause allergic airway inflammation, recombinant Der p 2 is proven to activate BEAS-2B cells inducing NFkB and producing inflammatory mediators. CD3/CD46-activated CD4 þ T cells from asthma subjects less to downregulate NF-kB/p65 expression in BEAS-2B cells may arise from defective IL-10 secretion. Some studies indicate IL-10 inhibiting NF-kB translocation, thus relieving airway inflammation. 5, 47, 48 IL-10-producing Tr1 cells have an important role in the pathogenesis and treatment of allergic asthma. 28, 49 Ni Choileain et al 50 demonstrated surface CD46 as cleaved by a metalloproteinase upon T-cell activation. Herein, CD46 expression on CD4 þ T cells decreased in bronchial tissue of mite sensitive asthmatic patients, hinting CD46 surface downregulation has a role during T-cell activation.
In summary, evidence shows decreased IL-10/granzyme B, CCR4 expression and chemotactic signaling pathway in CD3/ CD46-activated Tregs from asthma patients can explain dysfunctional ability to suppress mite-induced airway epithelial cell inflammation. It becomes conceivable to design therapeutic strategies manipulating Treg recruitment to attain tolerance and suppress airway inflammation in allergic asthma.
